Zhigang Wang

机构：CCCC Highway Consultants (China) · ORCID：0000-0002-7281-5845

发表论文 470 篇 · 总被引 12597 次 · h-index 61

代表论文

• LIFU-unlocked endogenous H2S generation for enhancing atherosclerosis-specific gas-enzymatic therapy (2024 · Biomaterials · 被引 20)
• The P2X7-Mediated Mitochondrial ROS as an Emerging Core Target of Tuftsin Nanoparticles in Severe Acute Pancreatitis Therapy via Regulating Mitophagy (2025 · ACS Applied Materials & Interfaces · 被引 10)
• Prostate cancer cell-derived exosomes inhibit macrophage phagocytosis through EIF3B-mediated exosomal sorting of miR-100-5p (2025 · Scientific Reports · 被引 5)
• LIFU (Low-Intensity Focused Ultrasound) Activated Tumor-Starvation/Oxidative-Stress Combined Therapy for Treating Retinoblastoma (2025 · International Journal of Nanomedicine · 被引 4)
• High BMI, silicone oil tamponade, and recurrent vitreous hemorrhage predict poor visual outcomes after pars plana vitrectomy in proliferative diabetic retinopathy (2025 · BMC Ophthalmology · 被引 4)
• TFAP4/DLGAP5 promotes tumor progression and macrophage M2 polarization in prostate cancer by activating the JAK2/STAT3 signaling (2025 · Experimental Cell Research · 被引 3)